On Dec. 3 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 30 - Dec. 2 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Nov. 29 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued two final rules, both effective Nov. 30, clarifying limits on irradiation of meat and poultry products. FDA is making the changes after investigations prompted by two 1999 petitions from the Food Safety and Inspection Service. The final rule for meat adds a new provision to FDA’s irradiation regulations on irradiation of meat at temperatures above refrigerated temperature, while the final rule for poultry clarifies the description of affected poultry products, removes a packaging limitation, and increases the acceptable level of irradiation to bring it into line with meat irradiation limits.
On Nov. 28 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for Nov. 28 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
The Food and Drug Administration may do a reinspection of Korean seafood processor Shinhan F&B Co.’s facility and assess associated fees, so the company “should consider providing [its] U.S Agent with a copy” of the associated warning letter, it said. The warning letter appears to be the first posted to the FDA website that contains language on U.S. agent liability for reinspection fees. FDA said the facility’s violations of the Seafood Hazard Analysis and Critical Control Point regulation constitute “noncompliance materially related to a food safety requirement of the Act,” and is therefore liable for the fees. FDA also threatened to place the facility’s products on detention without physical examination.
On Nov. 27 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration warned Korean device manufacturer Mi Gwang Contact Lens Co. that its premarket approval applications and federal contracts may be refused for violations of current good manufacturing practice (CGMP) requirements. The warning letter also detailed violations of the Medical Device Reporting regulation. FDA told the company to respond to the allegations with corrective actions within 15 days of receipt of the Nov. 13 letter.
During the week of Nov. 19-25, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of: